Cancer and Blood Disease Institute News

PhD student Shawn Barman is working to develop a new generation of gated CAR-T cell to more effectively treat acute myeloid leukemia.

Facing a new diagnosis? A pediatric oncologist explains what the care journey looks like for acute lymphoblastic leukemia, the most common form of childhood cancer.

Chimeric antigen receptor (CAR) T-cell therapy uses a person’s own immune cells that have been modified to recognize and attack cancer cells.

Postdoctoral Fellow Vic Zamloot, PhD, is researching how the extracellular matrix can protect neuroblastoma cells from treatment with immune-based therapies to help reveal new drug targets.

A nurse practitioner in CHLA’s Cancer and Blood and Disease Institute shares advice on having productive conversations with children and adolescents facing a new cancer diagnosis.

Chemotherapy and radiation treatments affect every patient differently. Here’s how parents can help their children prepare.

An international expert at CHLA talks about the state of hemophilia gene therapy—and what’s on the horizon.

Everything parents should know about spotting and preventing blood clots in children.

At age 9, Wallie and Noah were facing osteosarcoma—and a surgery that would change their lives forever. There was only one way to get through it: together.

A clinical trial at CHLA is studying virus-specific T-cell therapy as a potential treatment for newborns with congenital cytomegalovirus.